(SeaPRwire) –   International markets now account for roughly half of the company’s total revenue

KINGSVILLE, ON, May 28, 2026 – Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) (“Greenway” or the “Company”), a producer of premium greenhouse-grown cannabis for the Canadian market, is pleased to report the continued growth of its international sales operations, with global channels now contributing approximately 50% of the Company’s total sales.

Since initiating international exports in late 2024, Greenway has consistently expanded its footprint in global medical cannabis sectors through disciplined commercial execution and the cultivation of key strategic alliances.

The Company’s international growth strategy prioritizes the delivery of high-quality, greenhouse-cultivated cannabis to regions that demand consistency, superior product standards, and dependable supply chains. Greenway anticipates that global medical cannabis markets will continue to offer more favorable pricing per gram than the domestic market, thereby bolstering revenue potential while maintaining the Company’s commitment to cost-effective, efficient greenhouse production. This strategy is intended to diversify the Company’s income streams and support long-term commercial viability.

“International revenue has become a vital pillar of our operations,” stated Jamie D’Alimonte, CEO of Greenway. “Over the past year, we have collaborated closely with key strategic partners to steadily increase our presence in the global medical cannabis market, entering new regions and introducing new product lines. We believe this disciplined, measured approach fosters sustainable long-term growth while allowing us to capitalize on the efficiency of our greenhouse cultivation model.”

Greenway’s current selection of cultivars is designed to meet the needs of both domestic and international clients. As the export program scales, the Company has also introduced several new cannabis strains specifically tailored for international medical cannabis opportunities. These cultivars are being evaluated for key characteristics valued by global buyers, including flower quality, consistent cannabinoid profiles, terpene expression, and reliable THC levels.

Greenway expects these genetic advancements to facilitate the ongoing development of its global product range while strengthening relationships with overseas partners and customers.

“Our cultivation team is dedicated to producing flower that meets the shifting demands of both domestic and international markets,” D’Alimonte added. “As our export operations expand, we believe that developing cultivars specifically for international needs is a crucial step in evolving our platform and market reach.”

Greenway’s production strategy integrates large-scale greenhouse cultivation with a focus on premium flower quality, enabling the Company to remain competitive in both local and global markets while upholding rigorous cost management and operational consistency.

As global demand for medical cannabis continues to evolve, Greenway plans to keep exploring opportunities to broaden its international distribution network and increase its involvement in major overseas markets.

About Greenway

Greenway Greenhouse Cannabis Corporation is a federally licensed cannabis cultivator serving the Canadian market. Based in Kingsville, Ontario, Greenway utilizes its agricultural and cannabis industry expertise to strive toward becoming a leading Canadian producer. Further details are available at Greenway.ca, with updates posted on Instagram, Twitter, Facebook, and LinkedIn.

The CSE has not reviewed the merits of the Company’s business, has neither approved nor disapproved the information contained in this press release, and assumes no responsibility for the accuracy or adequacy of this release.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements that constitute forward-looking information under applicable Canadian securities laws. All statements herein that are not historical facts are considered forward-looking statements, including those regarding the Company’s beliefs, plans, expectations, future strategies, objectives, goals, targets, operational developments, and future orientations. While the Company believes these statements are reasonable and reflect management’s expectations regarding future developments, it cannot guarantee that these expectations will prove accurate. Forward-looking statements are often identified by terms such as “believes,” “expects,” “aims,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “should,” “would,” “will,” “potential,” “scheduled,” or similar terminology, which refer to future events or outcomes.

Forward-looking statements are subject to known and unknown risks, assumptions, uncertainties, and other factors that could cause actual results, performance, or achievements to differ materially from those projected, including the risks detailed in the Company’s final prospectus dated September 3, 2021, available on the Company’s profile at www.sedarplus.ca. These statements are made as of the date of this release, and the Company assumes no obligation to update them or the reasons why actual results might differ, except as required by law.

SOURCE Greenway Greenhouse Cannabis Corporation